Versant Capital Management »

Corvus Pharmaceuticals shares owned by Versant Capital Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $410 28 14.64

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Avago Technologies Stock (AVGO)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Vanguard Total Stk Mkt Etf (VTI)
State Street Spdr S&p Global Natural Resources Etf Etf (GNR)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)

View all positions for Versant Capital Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Foresite Capital Management VI
DCF Advisers
Perceptive Advisors
Millennium Management
Susquehanna International
Goldman Sachs Group

View all funds holding Corvus Pharmaceuticals